References

1. Aarskog, N. K. and Vedeler, C. A. Real-time quantitative polymerase chain reaction. Hum. Genet. 107:494-498, 2000.

2. Klein, D. Quantification using real-time PCR technology: applications and limitations. Trends Mol. Med. 8:257-260, 2002.

3. Zimmermann, B., Holzgreve, W., Wenzel, F., and Hahn, S. Novel real-time quantitative PCR test for trisomy 21. Clin. Chem. 48:362-363, 2002.

4. Yang, J. H., Lai, J. P., Douglas, S. D., Metzger, D., Zhu, X. H., and Ho, W. Z. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J. Virol. Methods 102:119-128, 2002.

5. Emig, M., Saussele, S., Wittor, H., et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 13:1825-1832, 1999.

6. Wittwer, C. T., Herrmann, M. G., Gundry, C. N., and Elenitoba-Johnson, K. S. Real-time multiplex PCR assays. Methods 25:430-442, 2001.

7. van der Velden, V. H., Hochhaus, A., Cazzaniga, G., et al Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 17:1013-1034, 2003.

8. Wilhelm, J., Reuter, H., Tews, B., Pingoud, A., and Hahn, M. Detection and quantification of insertion/deletion variations by allele-specific real-time PCR: application for genotyping and chimerism analysis. Biol. Chem. 383:1423-1433, 2002.

9. Tiemann, C., Vogel, A., Dufaux, B., Zimmer, M., Krone, J. R., and Hagedorn, H. J. Rapid DNA typing of HLA-B27 allele by real-time PCR using lightcycler technology. Clin. Lab. 47:131-134, 2001.

10. Donohoe, G. G., Laaksonen, M., Pulkki, K., Ronnemaa, T., and Kairisto, V. Rapid single-tube screening of the C282Y hemochro-matosis mutation by real-time multiplex allele-specific PCR without fluorescent probes. Clin. Chem. 46:1540-1547, 2000.

11. Livak, K. J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet. Anal.: Biomol. Eng. 14:143-149, 1999.

12. Abravaya, K., Huff, J., Marshall, R., et al. Molecular beacons as diagnostic tools: technology and applications. Clin. Chem. Lab. Med. 41:468-474, 2003.

13. Broude, N. E. Stem-loop oligonucleotides: a robust tool for molecular biology and biotechnology. Trends Biotechnol. 20:249-256, 2002.

14. Tapp, I., Malmberg, L., Rennel, E., Wik, M., and Syvanen, A. C. Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5'-nuclease TaqMan assay and Molecular Beacon probes. Biotechniques 28:732-738, 2000.

15. Tsourkas, A., Behlke, M. A., Rose, S. D., and Bao, G. Hybridization kinetics and thermodynamics of molecular beacons. Nucleic Acids Res. 31:1319-1330, 2003.

16. Ramachandran, A., Zhang, M., Goad, D., Olah, G., Malayer, J. R., and El-Rassi, Z. Capillary electrophoresis and fluorescence studies on molecular beacon-based variable length oligonucleotide target discrimination. Electrophoresis 24:70-77, 2003.

17. Neoh, S. H., Brisco, M. J., Firgaira, F. A., Trainor, K. J., Turner, D. R., and Morley, A. A. Rapid detection of the factor V Leiden (1691 G > A) and haemochromatosis (845 G > A) mutation by fluorescence resonance energy transfer (FRET) and real time PCR. J. Clin. Pathol. 52:766-769, 1999.

18. Wabuyele, M. B., Farquar, H., Stryjewski, W., et al. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes. J. Am. Chem. Soc. 125:69376945, 2003.

19. Whitcombe, D., Theaker, J., Guy, S. P., Brown, T, and Little, S. Detection of PCR products using self-probing amplicons and fluorescence. Nat. Biotechnol. 17:804-807, 1999.

20. Whitcombe, D., Kelly, S., Mann, J., Theaker, J., Jones, C., and Little, S. Scorpion primers—a novel method for use in single tube genotyping. Am. J. Hum. Genet. 65:2333, 1999.

21. Thelwell, N., Millington, S., Solinas, A., Booth, J., and Brown, T. Mode of action and application of Scorpion primers to mutation detection. Nucleic Acids Res. 28:3752-3761, 2000.

22. Brown, L. J., McKeen, C. M., Mellor, J. M., Nicol, J. T., and Brown, T. Synthesis of fluorophore and quencher monomers for use in Scorpion primers and nucleic acid structure probes. Organ. Biomol. Chem 1:2267-2275, 2003.

23. Solinas, A., Brown, L. J., McKeen, C., et al. Duplex Scorpion primers in SNP analysis and FRET applications. Nucleic Acids Res. 29:E96, 2001.

24. Cunnick, G. H., Jiang, W. G., Gomez, K. F., and Mansel, R. E. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. Biochem. Biophys. Res. Commun. 288: 1043-1046, 2001.

25. Saha, B. K., Tian, B., and Bucy, R. P. Quantitation of HIV-1 by realtime PCR with a unique fluorogenic probe. J. Virol. Methods 93:33-42, 2001.

26. Taveau, M., Stockholm, D., Spencer, M., and Richard, I. Quantification of splice variants using molecular beacon or scorpion primers. Anal. Biochem. 305:227-235, 2002.

27. Bates, J. A. and Taylor, E. J. A. Scorpion ARMS primers for SNP real-time PCR detection and quantification of Pyrenophora teres. Mol. Plant Pathol. 2:275-280, 2001.

28. Terry, C. F., Shanahan, D. J., Ballam, L. D., Harris, N., McDowell, D. G., and Parkes, H. C. Real-time detection of genetically modified soya using Lightcycler and ABI 7700 platforms with TaqMan, Scorpion, and SYBR Green I chemistries. J. AOAC Int. 85:938-944, 2002.

29. Frei, K., Szuhai, K., Lucas, T., et al. Connexin 26 mutations in cases of sensorineural deafness in eastern Austria. Eur. J. Hum. Genet. 10:427-432, 2002.

30. Marras, S. A., Kramer, F. R., and Tyagi, S. Multiplex detection of single-nucleotide variations using molecular beacons. Genet. Anal. 14:151-156, 1999.

31. Jebbink, J., Bai, X., Rogers, B. B., Dawson, D. B., Scheuermann, R. H., and Domiati-Saad, R. Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons. J. Mol. Diagn. 5:15-20, 2003.

32. Li, Y., Zimmermann, B., Zhong, X. Y., Gupta, A. K., Holzgreve, W., and Hahn, S. Determination of RHD zygosity using real-time quantitative PCR. Swiss Med. Wkly. 133:442-445, 2003.

33. Wilke, K., Duman, B., and Horst, J. Diagnosis of haploidy and triploidy based on measurement of gene copy number by real-time PCR. Hum. Mutat. 16:431-436, 2000.

34. Trinh, B. N., Long, T. I., and Laird, P. W. DNA Methylation analysis by MethyLight technology. Methods 25:456-462, 2001.

35. Eads, C. A., Danenberg, K. D., Kawakami, K., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28:E32, 2000.

36. Eads, C. A., Lord, R. V., Wickramasinghe, K., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61:3410-3418, 2001.

37. Elsayed, S., Chow, B. L., Hamilton, N. L., Gregson, D. B., Pitout, J. D., and Church, D. L. Development and validation of a molecular beacon probe-based real-time polymerase chain reaction assay for rapid detection of methicillin resistance in Staphylococcus aureus. Arch. Pathol. Lab. Med. 127:845-849, 2003.

38. Szuhai, K., Sandhaus, E., Kolkman-Uljee, S. M., et al. A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction. Am. J. Pathol. 159:1651-1660, 2001.

39. Hollox, E. J., Atia, T., Cross, G., Parkin, T., and Armour, J. A. High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH). J. Med. Genet. 39:790-795, 2002.

40. Newton, C. R., Graham, A., Heptinstall, L. E., et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17:2503-2516, 1989.

41. Wu, D. Y., Ugozzoli, L., Pal, B. K., and Wallace, R. B. Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc. Natl. Acad. Sci. USA 86:2757-2760, 1989.

42. Sommer, S. S., Cassady, J. D., Sobell, J. L., and Bottema, C. D. A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria. Mayo Clin. Proc. 64:1361-1372, 1989.

43. Kwok, S., Kellogg, D. E., McKinney, N., et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 18:999-1005, 1990.

44. Chiu, R. W., Murphy, M. F., Fidler, C., Zee, B. C., Wainscoat, J. S., and Lo, Y. M. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin. Chem. 47:667-672, 2002.

45. Rust, S., Funke, H., and Assmann, G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res. 21:3623-3629, 1993.

46. Schluter, B., Erren, M., Schotte, H., Junker, R., Rust, S., and Assmann, G. The mutagenically separated polymerase chain reaction is a rapid and reliable method for genotyping of the tumour necrosis factor-alpha promoter polymorphism (-308 G/A). Clin. Chim. Acta. 320:135-138, 2002.

47. Purandare, S. M., Cawthon, R., Nelson, L. M., et al. Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus. Am. J. Hum. Genet. 59:159-166, 1996.

48. Myint, L., Ariyoshi, K.,Yan, H., et al. Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 46:3861-3868, 2002.

49. Chang, J. G., Liu, H. J., Huang, J. M.,Yang, T. Y., and Chang, C. P. Multiplex mutagenically separated PCR: diagnosis of beta-thalassemia and hemoglobin variants. Biotechniques 22:520527, 1997.

50. Ferrie, R. M., Schwarz, M. J., Robertson, N. H., et al. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am. J. Hum. Genet. 51:251-262, 1992.

51. Cheadle, J., Myring, J., al-Jader, L., and Meredith, L. Mutation analysis of 184 cystic fibrosis families in Wales. J. Med. Genet. 29:642-646, 1992.

52. Kobayashi, K., Knowles, M. R., Boucher, R. C., O'Brien, W. E., and Beaudet, A. L. Benign missense variations in the cystic fibrosis gene. Am. J. Hum. Genet. 47:611-615, 1990.

53. Butler, J. M., McCord, B. R., Jung, J. M., Wilson, M. R., Budowle, B., and Allen, R. O. Quantitation of polymerase chain reaction products by capillary electrophoresis using laser fluorescence. J. Chromatogr. B. Biomed. Appl. 658:271-280, 1994.

54. Pertl, B., Yau, S. C., Sherlock, J., Davies, A. F., Mathew, C. G., and Adinolfi, M. Rapid molecular method for prenatal detection of Down's syndrome. Lancet 343:1197-1198, 1994.

55. Adinolfi, M., Pertl, B., and Sherlock, J. Rapid detection of aneuploi-dies by microsatellite and the quantitative fluorescent polymerase chain reaction. Prenat. Diagn. 17:1299-1311, 1997.

56. Pertl, B., Kopp, S., Kroisel, P. M., Tului, L., Brambati, B., and Adinolfi, M. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J. Med. Genet. 36: 300-303, 1999.

57. Mann, K., Fox, S. P., Abbs, S. J., et al. Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis. Lancet 358:1057-1061, 2001.

58. Hulten, M. A., Dhanjal, S., and Pertl, B. Rapid and simple prenatal diagnosis of common chromosome disorders: Advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction 126:279-297, 2003.

59. Pertl, B., Pieber, D., Panzitt, T., et al. RhD genotyping by quantitative fluorescent polymerase chain reaction: a new approach. BJOG 107:1498-1502, 2000.

60. Mansfield, E. S., Robertson, J. M., Lebo, R. V., et al. Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescence-based strategies. Am. J. Med. Genet. 48:200-208, 1993.

61. Bougeard, G., Brugieres, L., Chompret, A., et al. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 22:840-846, 2003.

62. Delahunty, C. M., Ankener, W., Brainerd, S., Nickerson, D. A., and Mononen, I. T. Finnish-type aspartylglucosaminuria detected by oligonucleotide ligation assay. Clin. Chem. 41:59-61, 1995.

63. Brinson, E. C., Adriano, T., Bloch, W., et al. Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis. Genet. Test. 1:61-68, 1997.

64. Grossman, P. D., Bloch, W., Brinson, E., et al. High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Res. 22:4527-4534, 1994.

65. Heath, K. E., Day, I. N., and Humphries, S. E. Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipopro-tein receptor gene. J. Med. Genet. 37:272-280, 2000.

66. Schouten, J. P., McElgunn, C. J., Waaijer, R., Zwijnenburg, D., Diepvens, F., and Pals, G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30:e57, 2002.

67. Hogervorst, F. B., Nederlof, P. M., Gille, J. J., et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 63:1449-1453, 2003.

68. Montagna, M., Palma, M. D., Menin, C., et al. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum. Mol. Genet. 12:1055-1061, 2003.

69. Nakagawa, H., Hampel, H., and de la Chapelle, A. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum. Mutat. 22:258, 2003.

70. Horowitz, M., Pasmanik-Chor, M., Borochowitz, Z., et al. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Hum. Mutat. 12:240-244, 1998. Erratum: Hum. Mutat. 13:255, 1999.

71. Karpati, M., Peleg, L., Gazit, E., Akstein, E., and Goldman, B. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin Clin. Genet. 57:398-400, 2000.

72. Drucker, L., Stackievitz, R., Shpitz, B., and Yarkoni, S. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study. Anticancer Res. 20:559-561, 2000.

73. Jordan, N., Williams, N., Gregory, J. W., Evans, C., Owen, M., and Ludgate, M. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. J. Clin. Endocrinol. Metab. 88:1002-1005, 2003.

74. Matyas, G., Giunta, C., Steinmann, B., Hossle, J. P., and Hellwig, R. Quantification of single nucleotide polymorphisms: a novel method that combines primer extension assay and capillary electrophoresis. Hum. Mutat. 19:58-68, 2002.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment